十一月 2025
- Home
- Imexpharm Corporation
十一月 2025的Imexpharm Corporation市场份额分析
Giải pháp toàn diện với thuốc ho phối hợp Imexpharm giúp điều trị giảm ho hiệu quả được sản xuất tại nhà máy dược EU-GMP chất lượng cao.
Imexpharm Corporation(包含公司地区分支机构)
查看更多网站流量和参与度信息- imexpharm.com
Imexpharm Corporation收入截至 十一月 2025为 50M - 75M
Imexpharm Corporation主要域名产生的收入
3 年中Imexpharm Corporation主要域名的收入
Imexpharm Corporation主要域名的收入
Imexpharm Corporation热门域名的总访问量
了解Imexpharm Corporation市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Imexpharm Corporation热门域名的平均访问时长
分析Imexpharm Corporation参与度指标。
过去 3 个月的平均访问时长
子公司明细
Imexpharm Corporation热门域名的平均页面浏览量
了解Imexpharm Corporation如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Imexpharm Corporation 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Imexpharm Corporation receives award Vietnam Pharmaceutical Star.Imexpharm Joint Stock Pharmaceutical Company has received the "Vietnam Pharmaceutical Star" award, which honors domestic pharmaceutical companies for significant contributions to healthcare, reaffirming its leading EU-GMP quality position in Vietnam.
五月 20, 2024阅读更多
新闻Imexpharm Corporation expands facilities to Vietnam.Imexpharm is currently the pharmaceutical company with the largest cluster of manufacturing facilities that follow European standards of Good Manufacturing Practice (EU-GMP) and has the highest number of EU-GMP production lines in Vietnam.
三月 6, 2024阅读更多
新闻Imexpharm Corporation receives award Board of The Year" Award 2023.Imexpharm has been awarded the "Board of The Year" Award 2023 by the Vietnam Institute of Directors for its good and diverse governance structures.
十二月 3, 2023阅读更多
查看 Imexpharm Corporation 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。